Hebei Changshan Biochemical Hits Day Low at CNY 24.40 Amid Price Pressure

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. experienced significant volatility on June 17, 2026, with the stock hitting an intraday low of CNY 24.40, reflecting a decline of 15.15% for the day. This performance starkly contrasts with the China Shanghai Composite, which saw a modest gain of 0.4% on the same day. Over the past week, Hebei Changshan has faced a steep decline of 33.53%, and its one-month performance shows a drop of 40.53%. Year-to-date, the stock has plummeted by 59.87%, while the broader market has gained 3.51%. The company's long-term financial metrics indicate challenges, with a return on capital employed (ROCE) of just 3.59% and a troubling trend in net sales, which have decreased at an annual rate of 20.03% over the last five years. Despite being net-debt free, Hebei Changshan has reported negative results for four consecutive quarters, with a net profit of CNY -322.94 million for the first nine months, reflecting a decline of 62.45%. The stock's performance has significantly underperformed the market, highlighting ongoing financial difficulties within the company.